Trends in Glaucoma Medication Expenditure

The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study

“…Both studies found an increased use of prostaglandin analogs along with a decreased use of β-blockers. The only significant difference from the current study was an increased use of α2-adrenergic agonists among the American population[ 19 ]. The lack of increase in α2-adrenergic agonist treatment in Denmark may be due to the unavailability of the α2-adrenergic agonist suspension, Alphagan P, which has been shown to cause significantly fewer cases of allergy compared to the European suspension[ 19 , 21 ].…”

The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study

“…Both studies found an increased use of prostaglandin analogs along with a decreased use of β-blockers. The only significant difference from the current study was an increased use of α2-adrenergic agonists among the American population[ 19 ]. The lack of increase in α2-adrenergic agonist treatment in Denmark may be due to the unavailability of the α2-adrenergic agonist suspension, Alphagan P, which has been shown to cause significantly fewer cases of allergy compared to the European suspension[ 19 , 21 ].…”

Ophthalmic Medication Expenditures and Out-of-Pocket Spending

“…Here, we demonstrate that national expenditures for prescription ophthalmic medications have substantially grown, nearly doubling from 2007-2008 to 2015-2016, continuing the trend of rising expenditures reported by studies examining data from 2001-2006. 16,17 Our results indicate that this growth was driven by both an increasing number of individuals utilizing ophthalmic medications as well as greater per capita spending. Furthermore, the average price per prescription grew while the number of prescriptions per individual remained stable, suggesting that rising ophthalmic drug prices and greater use of expensive brand medications may be contributing more to growing expenditure than more frequent utilization.…”

Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan

“…In this study, expenditures for glaucoma medications were significantly higher for men than for women, whereas in the USA the opposite is true [8]. The possible reasons are differences in knowledge of health issues between genders in different societies and the higher prevalence of ACG in Taiwan [2, 17].…”

The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study

“…Both studies found an increased use of prostaglandin analogs along with a decreased use of β-blockers. The only significant difference from the current study was an increased use of α2-adrenergic agonists among the American population[ 19 ]. The lack of increase in α2-adrenergic agonist treatment in Denmark may be due to the unavailability of the α2-adrenergic agonist suspension, Alphagan P, which has been shown to cause significantly fewer cases of allergy compared to the European suspension[ 19 , 21 ].…”

Ophthalmic Medication Expenditures and Out-of-Pocket Spending

“…Here, we demonstrate that national expenditures for prescription ophthalmic medications have substantially grown, nearly doubling from 2007-2008 to 2015-2016, continuing the trend of rising expenditures reported by studies examining data from 2001-2006. 16,17 Our results indicate that this growth was driven by both an increasing number of individuals utilizing ophthalmic medications as well as greater per capita spending. Furthermore, the average price per prescription grew while the number of prescriptions per individual remained stable, suggesting that rising ophthalmic drug prices and greater use of expensive brand medications may be contributing more to growing expenditure than more frequent utilization.…”

Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan

“…In this study, expenditures for glaucoma medications were significantly higher for men than for women, whereas in the USA the opposite is true [8]. The possible reasons are differences in knowledge of health issues between genders in different societies and the higher prevalence of ACG in Taiwan [2, 17].…”

The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study

“…Both studies found an increased use of prostaglandin analogs along with a decreased use of β-blockers. The only significant difference from the current study was an increased use of α2-adrenergic agonists among the American population[ 19 ]. The lack of increase in α2-adrenergic agonist treatment in Denmark may be due to the unavailability of the α2-adrenergic agonist suspension, Alphagan P, which has been shown to cause significantly fewer cases of allergy compared to the European suspension[ 19 , 21 ].…”

Ophthalmic Medication Expenditures and Out-of-Pocket Spending

“…Here, we demonstrate that national expenditures for prescription ophthalmic medications have substantially grown, nearly doubling from 2007-2008 to 2015-2016, continuing the trend of rising expenditures reported by studies examining data from 2001-2006. 16,17 Our results indicate that this growth was driven by both an increasing number of individuals utilizing ophthalmic medications as well as greater per capita spending. Furthermore, the average price per prescription grew while the number of prescriptions per individual remained stable, suggesting that rising ophthalmic drug prices and greater use of expensive brand medications may be contributing more to growing expenditure than more frequent utilization.…”

Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan

“…In this study, expenditures for glaucoma medications were significantly higher for men than for women, whereas in the USA the opposite is true [8]. The possible reasons are differences in knowledge of health issues between genders in different societies and the higher prevalence of ACG in Taiwan [2, 17].…”